Company news
Luye Pharma Group Ltd. news in 2023
Luye Pharma Group Ltd.'s news releases, calls and decks from 2023, newest first.
Luye Pharma Announces the Approval of Lurbinectedin for the Treatment of Relapsed Small Cell Lung Cancer in Hong Kong
December 12, 2023
Rivastigmine Twice Weekly Transdermal Patch Approved in China for the Treatment of Alzheimer's Disease
October 31, 2023
The World’s Only Goserelin Microsphere Formulation (Baituowei) Approved in China for the New Indication of Breast Cancer
September 7, 2023
Luye Pharma Announces 2023 Half Year Results
August 30, 2023
Luye Pharma Group: China’s NMPA Accepts and Grants Priority Review Designation to the New Drug Application for Luye Pharma’s Rotigotine Extended-Release...
August 1, 2023
Patient Enrollment Completed for a Phase 2 Clinical Study of Luye Pharma’s Class 1 Analgesic Drug Candidate LY03014
July 6, 2023